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Cloning of the Canine ABCA4Gene and Evaluation in Canine Cone-Rod
Dystrophies and Progressive Retinal Atrophies
Abstract
PURPOSE: To characterize a novel early onset canine retinal disease, and evaluate the ATP-binding cassette
transporter gene ABCA4 as a potential candidate gene in this and other canine retinal degenerations.
METHODS: Retinal disease was characterized ophthalmoscopically and electroretinographically in two pit
bull terrier dogs and their purpose-bred descendants. All 50 exons of the canine ABCA4 gene were amplified,
cloned and sequenced from retinal mRNA of a normal, a carrier and an affected animal, and polymorphisms
identified. The latter were used to search for association between ABCA4 and retinal disease both within the
study pedigrees and in additional canine breeds segregating retinal degenerations.
RESULTS: The disease derived from either founder is distinguished by early, severe, and rapidly progressive
loss of cone function accompanied by progressive rod loss that is only relatively slower. Cloning and
comparative sequencing of ABCA4 identified six point mutations, none of which were obviously pathogenic.
Crossbreeding studies revealed that the diseases in the two founders, although similar, are nonallelic. Pedigree
analysis of segregating polymorphisms revealed dissociation between ABCA4 and both retinal phenotypes.
CONCLUSIONS: The early, severe cone dysfunction in these diseases distinguish them from other forms of
canine Progressive Retinal Atrophy. The development of a research population segregating these diseases
presents two large animal models for the heterogenous human diseases termed cone-rod dystrophies. Analysis
of the canine ABCA4 homolog gene documented its sequence and identified a set of point mutations that
were used to exclude this gene as causal to these canine cone-rod dystrophies.
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 Hereditary retinal degenerations form a diverse spectrum
of blinding disorders that affect humans and other mammals.
Those diseases recognized in non-human species provide in-
valuable model systems for studies of disease pathogenesis
and the evaluation of treatment strategies. Such models are of
particular value when their genetic basis is well understood
and they faithfully reproduce the phenotypic characteristics
of human disease. Naturally occurring canine hereditary reti-
nal degenerations, such as the T4R opsin mutant dog [1], sat-
isfy these criteria and can facilitate experiments which are
currently difficult or impossible in other organisms. The dem-
onstration of gene therapy mediated vision restoration within
a canine model of Leber congenital amaurosis (LCA) is a pow-
erful example [2].
Causal mutations for an increasing number of canine he-
reditary retinal degenerations are being determined. For ex-
ample, pathogenic mutations have been identified in the ca-
nine PDE6A and PDE6B genes for the α and β subunits of the
cGMP specific phosphodiesterase [3,4], the RPE65 gene[5],
the RP GTPase regulator RPGR [6], the cone-specific cyclic
nucleotide-gated channel β subunit gene CNGB3 [7] and
rhodopsin RHO [1]. The resulting disorders model autosomal
recessive, autosomal dominant, and X-linked retinitis
pigmentosa (PDE6A and PDE6B, RHO, and RPGR, respec-
tively), Leber congenital amaurosis (RPE65) and achromatop-
sia (CNGB3). With the exception of achromatopsia, these ca-
nine diseases are all rod-cone degenerations or dysplasias, in
which rod disease, dysfunction, and death precede loss of
cones; they are collectively termed Progressive Retinal Atro-
phy (PRA) and are homologous to human Retinitis Pigmentosa
(RP). There is as yet no published animal model correspond-
ing to the human cone-rod dystrophies (CRD), a group of dis-
orders distinguished from rod-cone degenerations, such as RP,
by the relatively earlier loss of cone function in CRD. In some
CRD patients cone dysfunction markedly precedes rod loss,
but in others there is concurrent cone and rod dysfunction.
Currently, eight human CRD loci and seven causal genes
(RetNet) are recognized.
Mutations in the ATP-binding cassette transporter gene
(ABCA4) have been associated with a diversity of human reti-
nal disorders. Over 200 unique human ABCA4 sequence vari-
ants have been reported from patients affected with cone-rod
dystrophy, Stargardt macular dystrophy, age related macular
degeneration (AMD), and autosomal recessive RP [8-11].
The ABCA4 gene, a member of the ATP-binding cassette
(ABC) transporter superfamily, is only expressed in rod pho-
toreceptors of the retina [12] and its precise role in membrane
transport remains an open question. The human gene com-
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Purpose: To characterize a novel early onset canine retinal disease, and evaluate the ATP-binding cassette transporter
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and their purpose-bred descendants. All 50 exons of the canine ABCA4 gene were amplified, cloned and sequenced from
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gating retinal degenerations.
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prises 50 exons covering more than 100 kB of genomic se-
quence on chromosome 1p22.1 [13]. The canine homolog of
this gene has not yet been characterized.
We now report an early onset PRA-like disease derived
from pit bull terriers, that shares clinical features with the hu-
man cone rod dystrophies. A resource strain of such dogs has
now been developed to allow characterization of the disease
phenotype and identification of the causal mutation. To evalu-
ate ABCA4 as a candidate gene in this and other canine dis-
eases, the canine ABCA4 homolog has been sequenced and
mapped on the canine genome.
METHODS
Animals and pedigrees:  Two independently acquired dogs
were used as founders for the study pedigrees (animals 1 and
3, Figure 1). These founders were both of pit bull terrier an-
cestry, but were not known to be related to each other. Animal
1 was outbred to two beagle derived crossbred dams (N2, N3)
known to be free of retinal degenerative disease alleles. The
resulting heterozygous offspring were either interbred, or back-
crossed to an affected dog to generate 29 animals segregating
the disease phenotype (Figure 1). Animal 2 was bred to a ho-
mozygous normal sire (N1) to produce obligate heterozygous
offspring which were then interbred to generate 15 F2 ani-
mals segregating the disease phenotype (Figure 1). Comple-
mentation tests to investigate disease allelism were performed
by mating two descendants (animals 14 and 78, Figure 1) of
the first founder (animal 1, Figure 1) either directly to the sec-
ond founder (animal 3, Figure 1) or to one of her affected
descendants (animal 78, Figure 1), respectively. The subse-
quent crossbred strains segregating these retinal degeneration
phenotypes are maintained at the Retinal Disease Studies Fa-
cility, Kennet Square, PA. All animal procedures were in ac-
cordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
Retinal tissue for RNA analysis (see below) was collected
from three animals; blood samples for segregation analysis
was collected from a total of 31 animals. Additional blood
samples were obtained from 67 privately owned dogs from
the following 11 breeds of dogs with PRA (number of affected
individuals given in parenthesis): akita (4), American cocker
spaniel (5), American eskimo dog (3), Australian cattle dog
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Figure 1. Study pedigree of dogs segregating cone-rod dystrophy.  Two affected pit bull terriers (animals 1 and 3) were outcrossed to homozy-
gous normal animals (N1-3). Heterozygous offspring were then either intercrossed or bred to affected animals to generate informative litters.
Electroretinography was used to determine the presence of the disease. Affected animals are denoted by solid symbols while asymptomatic
animals are illustrated either with half filled (where obligate heterozygotes) or empty symbols (where both parents are non-affected and status
at the mutation is unknown). Complementation test-breedings resulted in animals 29-37, and 150-151, all ten of which were non-affected,
establishing that the diseases derived from animals 1 and 3, although phenotypically similar, are non-allelic.
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(3), basenji (4), English springer spaniel (4), Glen of Imaal
terrier (4), Italian greyhound (4), papillon (4), poodle (3) and
Tibetan terrier (5).
Phenotypic ascertainment:  Diagnosis of retinal pheno-
type in all colony dogs was established by electroretinogra-
phy[14,15], and confirmed by clinical examination including
indirect ophthalmoscopy. Diagnosis of retinal phenotype in
non-colony dogs was by indirect ophthalmoscopy. In selected
cases, eyes were enucleated immediately postmortem and fixed
either for high resolution retinal morphological examination,
or for standard histopathologic examination as described pre-
viously [14,16]
Cloning of canine ABCA4:  Total RNA was isolated from
retinal tissue using TRIzol (Invitrogen, Carlsbad, CA) and a
single chloroform extraction. First strand cDNA was synthe-
sized in 20 µl reactions using an oligo d(T)16 primer and the
GeneAmp RNA PCR kit by following the manufacturers rec-
ommendations (Perkin Elmer, Foster City, CA). Nine pairs of
canine specific primers were designed to amplify overlapping
fragments spanning the 6810 bp ABCA4 translated region
(Table 1). First strand cDNA was amplified in 20 µl reactions
containing 0.4 µM both forward and reverse primer (Table 1),
1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 200
µM dNTP, and 0.5 U Taq polymerase. For each primer pair
the PCR annealing temperature was set at 55 °C for 35 cycles
in a thermal cycler (PTC-200, MJ Research, Waltham, MA).
Following electrophoresis on 2% agarose gels, amplified frag-
ments were excised, purified and directly sequenced using dye
terminator chemistry and an ABI 3700 DNA sequencer (Ap-
plied Biosystems, Foster City, CA). DNA sequences were
aligned using Sequencer software (Gene Codes Corporation,
Ann Arbor, MI) and estimates of nucleotide diversity calcu-
lated using MEGA version 2.0 [17].
Analysis of ABCA4 polymorphism:  A non-synonymous
A to C transversion at nucleotide 1880 was detected in the
PCR fragment amplified from primers ABCA4-ex13F and
ABCA4-ex13R (Table 1) using the conditions described above.
Digestion of the 134 bp fragment with Aci (GCGG) into two
fragments (96 bp and 36 bp) reports the presence of C at posi-
tion 1880 while presence of the undigested fragment reports
presence of A at position 1880. A non-synonymous G to A
transition at nucleotide 3958 was detected in the PCR frag-
ment amplified from primers ABCA4-ex27F and ABCA4-
ex27R (Table 1) using the same conditions. Digestion of the
146 bp fragment with PstI (CTGCAG) into two fragments
(122 bp and 24 bp) reports the presence of G at position 3958
while presence of the undigested fragment reports presence
of A at position 3958. An estimate of linkage disequilibrium
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TABLE 1. PRIMERS USED FOR THE RT-PCR BASED CLONING OF THE
CANINE ABCA4 GENE
                                              STS
     Primer           Sequence (5'-3')         bp     Exons
----------------   ------------------------   ----   --------
      17B          ATGTCCTTTCCTGTCGCTGCACC     597   5’UTR-4
      18           CAACTGAGTCAGACAGGCCAATGT
       1           ACCTTGTCTCGACTCATGGACACC   1053     4-11
       2           GAAGTTCAGCATGGCTTCTGCAG
       3a          CACAGATGACCATGATCAGAGAC    1197    11-16
       4a          GGAGCATCATCTTCATGGACATC
       5           TTGGCACTGAGTACCTGGCTCGCT   1077    16-23
       6           TCTTGCGCACCAAGGTTAAG
       7           TGTCCACTCACCACATGGACGA     1402    23-33
       8b          ATCTGGCCAAGGTGGCTTAA
       9           GAGCAAATTCTGGGTCAAT         796    32-38
      10           GATGAAGGTGATGGCACTGCTG
      11           CAGCACAGCCTATGTGGCCTTG      623    38-43
      12           CGTCACCTGAGGTCACTGTGGT
      13           GTCTTCTGGGAGTGAATGGAGCT     572    43-47
      14           GACTTGAGATGCTGAATGGTGC
      15           GAGGAGTGTGAGGCTCTGTGTA      522   47-3’UTR
      16A          GGTCCAATCAGATGACCATAT
ABCA4-ex13SNPFor   CTGATCCTGTGGAAGACTTCC       134   exon 13
ABCA4-ex13SNPRev   GTAAGGCATCTGCTGGAGATAG
ABCA4-ex27SNPFor   CAGGGCTCCAATGGCTGCTCT       146   exon 27
ABCA4-ex27SNPRev   TGGTGGAATCGCTTGACCAGCAA
Nine pairs of canine specific primers were designed to amplify over-
lapping fragments spanning the 6810 bp ABCA4 translated region.
Primers were designed based on Genbank entries AY427777,
AY427778, and AY427779.
TABLE 2. ABCA4 GENOTYPES IN PRA AFFECTED AND NORMAL
ANIMALS
                 PRA Affected dogs            Non-affected dogs
             --------------------------   --------------------------
                      Exon 13   Exon 27            Exon 13   Exon 27
  Breed      Number     SNP       SNP     Number     SNP       SNP
----------   ------   -------   -------   ------   -------   -------
akita          2        C/C       A/A       -         -         -
               1        A/C       A/A       -         -         -
               1        C/C       G/G       -         -         -
               -         -         -        1        C/C       A/G
               -         -         -        1        A/C       A/G
American       4        C/C       A/A       1        C/C       A/A
cocker         1        A/C       A/G       -         -         -
spaniel
American       3        C/C       A/A       2        C/C       A/A
Eskimo
Australian     1        A/A       G/G       1        A/A       G/G
cattle dog     1        A/A       A/G       -         -         -
               1        A/C       A/G       -         -         -
basenji        1        A/A       A/A       -         -         -
               1        A/A       G/G       1        A/A       G/G
               2        A/A       A/G       1        A/A       A/G
English        1        A/C       A/A       1        A/C       A/A
springer       3        C/C       A/A       2        C/C       A/A
spaniel
Glen of        4        A/A       G/G       1        A/A       G/G
Imaal          -         -         -        1        A/C       A/G
terrier
Italian        1        A/A       A/A       2        A/A       A/A
greyhound      3        A/A       A/G       1        A/A       A/G
papillon       1        A/A       A/G       -         -         -
               1        A/C       A/A       -         -         -
               2        C/C       A/A       2        C/C       A/A
poodle         1        A/A       A/A       -         -         -
               1        A/A       A/G       2        A/A       A/G
               1        A/C       A/A       1        A/C       A/A
               -         -         -        1        A/A       G/G
Tibetan        2        C/C       A/A       2        C/C       A/A
terrier        3        A/C       A/G       -         -         -
Genotypes at two ABCA4 SNPs determined for a panel of 67 dogs
(43 affected by PRA, 24 nonaffected) representing 11 breeds.
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(D’) between the two positions was calculated from the ani-
mal set contained in Table 2. Compound heterozygotes (7/67)
were first excluded where unambiguous phase could not be
assigned before D’ was estimated using DnaSP version 3.53
[18]. Amplification of ABCA4 associated CFA6 microsatellites
C06.636 and 2A11 was performed using previously published
fluorescently labeled primers and conditions[19]. Amplified
alleles were genotyped using an ABI310 Genetic Analyzer and
GeneScan software (Applied Biosystems, Foster City, CA).
Radiation hybrid mapping:  Nine previously published
CFA6 genetic markers were used for radiation hybrid map
construction; 2A11, AHTH228, C06.636, FH2164, FH2370,
REN149M14, REN152F02, REN37H09 and VCAM1[19,20].
Amplification of each was performed as described on the
FHCRC Dog Genome Project / Radiation Hybrid Mapping
PCR Protocols webpage. Canine ABCA4 was mapped using a
146 bp fragment of exon 27 amplified by primers ABCA4-
ex27F and ABCA4-ex27R and an annealing temperature of
55 °C. PCR was performed for each marker using DNA from
the 92 cell RH083000 canine-hamster panel (Research Genet-
ics, Huntsville, AL). Using Multimap [21], the linkage groups
were defined where members returned two point Lod scores
higher than 5.0. These marker groups were then ordered in
relation to one another based on previously published RH and
meiotic maps [19].
RESULTS
Canine model of cone-rod dystrophy:  Both founder dogs (Ani-
mals 1 and 3, Figure 1) were young adults when first pre-
sented for clinical examination. Each dog exhibited marked
loss of visually guided behaviour and widely dilated pupils
under dim or bright ambient illumination, and was diagnosed
ophthalmoscopically as affected with an advanced retinal de-
generation. Electroretinographic responses of both dogs were
essentially flat lines to stimuli under conditions that normally
elicit distinct rod and cone responses (data not shown).
Younger dogs from subsequent generations demonstrated
a clinical phenotype markedly different from previously de-
scribed forms of PRA. Distinct pupillary dilatation, severe
visual difficulties under well lit conditions, and intermittent
nystagmus were present as soon after weaning as these signs
could be evaluated. Electroretinograms (ERGs), recorded from
all pups in informative litters as soon after weaning as practi-
cable, demonstrated severe dysfunction of both cones and rods,
with cone function consistently more severely impaired than
that of rods; in some cases cone function was unrecordable.
These findings were, broadly, similarly abnormal in affected
dogs derived from either founder. All responses from such
young affected dogs (Figure 2, columns 2, 3) were markedly
reduced in amplitude compared to age matched non-affected
dogs (Figure 2, column 1). Both rod-specific (Figure 2, line 2
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Figure 2. Electroretinograms from normal and cone-rod dystrophic dogs.  Electroretinograms recorded from representative normal (column 1)
and cone rod dystrophic (columns 2, 3) dogs. Each vertical panel presents the responses to a red flash (line 1); a blue flash (line 2); a white flash
(line 3); 5 Hz low intensity white light flashes (line 4); and 30 Hz high intensity white light flicker (lines 5, 6): These elicit rod-specific (lines
2, 4), cone-specific (lines 5, 6, 7) and mixed rod-cone responses respectively. Animal 53 derives its disease from one founder (Animal 3,
Figure 1) and Animal 27 from the other (Animal 1, Figure 1). Because these diseases are nonallelic they are termed crd1 and crd2, respectively.
Although both cone and rod responses are markedly reduced in both affected dogs, the reduction in cone response amplitudes, relative to the
loss of rod function, is far more severe than in previously described canine rod-cone degenerations and dysplasias. Residual cone function, at
this age, is better preserved in animal 53 than Animal 27, a consistent albeit slight difference between CRD1 and CRD2 affected animals.
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and 4) and cone-specific (Figure 2, lines 5, 6 and 7) stimuli
produced tiny or virtually absent responses from affected dogs.
Stimuli eliciting mixed rod-cone responses (Figure 2, lines 1
and 3) were also markedly reduced in amplitude in affected
dogs compared to non-affected. Ophthalmoscopic evidence
of retinal thinning became apparent in affected pups between
3 months and 6 months of age. By 12 months of age all af-
fected dogs demonstrated fixed dilated pupils, advanced gen-
eralized retinal degeneration on ophthalmoscopic examina-
tion, non-recordable ERG responses, and were clinically blind.
Morphologic examination of affected eyes examined to date
reveal only diffuse severe retinal degeneration in dogs over 6
months of age (data not shown).
Eight pups (Animals 29-37, Figure 1) were produced by
breeding one of the founders (Animal 3, Figure 1) to an obli-
gate heterozygous son (Animal 14, Figure 1) of the other
founder. Two further pups (Animals 150, 151, Figure 1) were
produced by breeding affected descendants of either founder
to each other. Each of the 8 pups from the first litter was ex-
amined clinically and electroretinographically at 11 weeks and
5 months of age, and their retinas were examined morpho-
logically at 5 months of age. The 2 pups from the second litter
were examined clinically and electroretinographically at 8
weeks of age. All observations were within normal limits and
none of the ten pups was affected with the retinal disease seg-
regating in other litters of the study pedigree (data not shown).
Cloning of canine ABCA4:  The genomic ABCA4 sequence
present within the December 2001 freeze of the human public
draft sequence (found on the UCSC Genome Bioinformatics
Site) was used to search the x1 database of the canine genome
constructed by The Institute for Genome Research (TIGR).
Of the 50 exons contained within the human query, partial or
complete sequence hits were returned for 23 canine exons.
This enabled design of canine specific primers for RT-PCR
amplification of ABCA4. cDNA derived from both crd and
normal retinal mRNA was amplified using nine primers sets
(Table 1). Comparison of the amplified fragments from each
mRNA preparation revealed products of the same length, in-
dicating normal ABCA4 splicing within the dystrophic reti-
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               9   9   9   9   9   0         2   2   2        3   3   3   4   4
               5   6   7   8   9   0         3   4   5        7   8   9   0   1
HumanABCA4    Glu Asn Val Asn Pro Arg       Gly Ala Pro      Pro Glu Cys Pro Gly
MouseABCA4    ... Gln Ala Gly Leu ...       ... --- Gln      ... ... Asp ... ...
CanineABCA4   ... ... --- --- Leu ...       Glu --- ...      ... ... --- Ala Arg
HumanABCA4    GAA AAC GTC AAC CCC CGA       GGG GCG CCG      CCA GAG TGC CCA GGC
MouseABCA4    ... C.A .C. GGT .T. ..G       ..A --- .AA      ... ... GA. ..C ..T
CanineABCA4   ... ... --- --- .T. ...       .A. --- ..A      ... ... --- G.. C..
Figure 3. Partial alignment of human, mouse and canine ABCA4 amino acid and nucleotide sequences.  Alignment of ABCA4 from three
species showing the position of missing residues in the dog. Amino acid residue numbers are given above the alignments of both protein (top)
and nucleotide (bottom) sequence. Positions absent from non-human species are denoted with (-) and numbered in red type.
Figure 4. Position of ABCA4 on CFA6.  A whole-genome dog/ham-
ster RH3000 panel was used and the order of backbone markers (un-
derlined) was chosen according to previous publication [19]. The
map was extended with statistical support >100:1. The map is di-
vided into three linkage groups based on two point linkage, and all
distances correspond to cR3000 units. Corresponding cytogenetic po-
sition of genes on human chromosomes are shown (right panel)
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nas. Single PCR products of the expected length were obtained
in every instance suggesting the presence of only one ABCA4
retinal transcript in both normal and dystrophic retina.
High level of interspecies conservation:  Pairwise nucle-
otide diversity was calculated between the human, mouse and
canine ABCA4 sequence homologs. At synonymous sites, the
nucleotide diversity (KST) between human and mouse ABCA4
was 0.534±0.025 substitutions/site which is approximately
equal to the average for genes compared between these lin-
eages (average KS=0.566 subs/site derived from a set of 45
genes, [22]). The nucleotide diversity at non-synonymous sites
(KN)=0.059±0.003 revealed the gene has a much lower than
average number of coding level substitutions (average
KN=0.125 subs/site, [22]). Pairwise diversity calculations in-
cluding the cloned canine ABCA4 sequence revealed lower
divergence from the human compared to the mouse gene at
both synonymous and non-synonymous sites (KS=0.356±0.018
canine v human, KS=0.571±0.026 canine v mouse;
KN=0.046±0.003 canine v human, KN=0.063±0.004 canine v
mouse). Comparison of the predicted amino acid sequence
revealed the canine ABCA4 has four missing residues when
compared with the human molecule (Figure 3). Each of the
four missing residues is located within a 42 amino acid region
located within the first intracellular loop. Comparison of
interspecies amino acid level diversity reveals this region has
accumulated many more changes (K=0.215±0.043; 93 resi-
dues) than the average for the entire molecule (K=0.096±0.006;
2266 residues). Interspecies comparison of the 12 transmem-
brane domain alpha-helical segments revealed few differences
(K=0.087±0.018; 242 residues) while no differences were
observed within the two ATP binding sites (residues 963-971
and 1972-1980).
Radiation hybrid mapping of canine ABCA4:  Human
ABCA4 is located on 1p22.1 in a region estimated to be syntenic
with canine chromosome 6 (CFA6) [19]. To reconstitute a
portion of the CFA6 RH map and test for linkage with ABCA4,
primers amplifying nine published canine markers and ABCA4
exon 27 were tested on the RH083000 canine-hamster RH panel.
Figure 4 shows ABCA4 in tight linkage with marker FH2370
confirming its location on CFA6 (two point LOD=14.0).
ABCA4 sequence from normal and crd retina:  The com-
plete 6810 bp coding region was sequenced and compared
between a crd affected dog (animal 22: crd/crd; GenBank ac-
cession number AY427777), a non-affected littermate (ani-
mal 23: crd+ or +/+; GenBank accession number AY427778)
and a beagle derived crossbred animal known to be homozy-
gous wildtype for the crd mutation (animal P1117: +/+;
GenBank accession number AY427779). Alignment revealed
an expressed ABCA4 transcript of the same length from each
animal. A total of six point-mutations were identified consist-
ing of three synonymous and three non-synonymous substitu-
tions (Figure 5). Two of the six mutations were observed in
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Figure 5. Nucleotide and amino acid substitutions identified within the canine ABCA4 gene.  Nucleotide and amino acid sequence variations
are shown for both chromosomes for each of 3 animals (AS22 is Animal 22, genotype crd/crd; AS23 is Animal 23, genotype +/; Animal P1117,
genotype +/+) and compared to the corresponding human sequence. Six polymorphisms (within codons 101, 147, 196, 627, 1322 and 1747, as
identified in the top label) are present among the canine sequences. Complete sequence (nucleotide in top set, amino acid in bottom set) is only
shown for one chromosome of AS22 (top row of each set), for other data rows only the variant allele is shown (dots represent conserved
sequence identities). Chromatograms (bottom figures) demonstrate sequence traces from one animal per polymorphism (red is T, blue is C,
black is G, green is A), with arrows indicating the polymorphic site. Thus, P1117 is TT at the polymorphic site in codon 101, AG in 147, AT in
196, AC in 626, and AG in 1322; and AS22 is AG in 1747.
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the heterozygous state within the affected animal 22 while
another three were observed only within the homozygous
wildtype animal P1117 (Figure 5). The three non-synonymous
substitutions result in amino acid replacements Glu627Ala,
Thr1322Ala, and Val1747Ile, none of which have to date been
implicated in the pathogenesis of retinal disease in other spe-
cies.
Association analysis in crd1 and crd2 pedigrees:  In the
absence of clearly pathogenic exonic sequence variants, asso-
ciation analysis was conducted to investigate the segregation
of the identified ABCA4 polymorphisms within the resource
pedigrees. Restriction endonuclease based diagnostic PCR
assays were designed to determine the nucleotide sequence at
both the Glu627Ala and Thr1322Ala mutations. Genotypic
data from these two ABCA4 polymorphisms and two CFA6
microsatellites (CFA6-2A11 and C06.636) permitted construc-
tion and examination of chromosomal haplotypes within the
disease pedigrees. Assuming a recessive mode of inheritance,
symptomatic F2 animals are predicted to possess the same
haplotype combination as their affected grandparent for the
chromosomal region containing the casual mutation. Inspec-
tion of the CFA6 haplotypes present within a number of F2
animals showed this was not the case (Figure 6). The affected
F2 animal 27, for example, inherited a chromosomal haplo-
type [180-C-A-160 from markers CFA6-2A11, Glu627Ala,
Thr1322Ala, C06.636] from its homozygous normal grand-
mother (animal N3). Similar analyses of a further seven af-
fected and eight non-affected F2 animals revealed a total of
eight animals which were discordant between their CFA6
haplotypes and their cone-rod dystrophic phenotype (animals
17, 18, 20, 27, 40, 41 55, 56). This clearly excludes ABCA4
and the surrounding CFA6 region as causal to the disease origi-
nating from both founding animals.
Association analysis with canine PRA:  Two identified
ABCA4 polymorphisms were also genotyped in a set of PRA
affected and non-affected animals from 11 additional dog
breeds. Table 2 shows that affected members in nine of the
eleven breeds were heterozygous at one or both of the poly-
morphic positions. One of the remaining two breeds (akita)
has affected members homozygous for different haplotypes
while the second breed (Glen of Imaal terrier) has PRA af-
fected animals sharing the same homozygous genotype with
phenotypically normal animals. Examination of the haplotypes
arising from the two polymorphic positions revealed all four
theoretically possible genotypic combinations were observed
in the set of 67 dogs. The two SNPs are tightly linked but not
in complete linkage disequilibrium (D’=0.844).
DISCUSSION
 The development of animal models of ocular disease is re-
quired for the testing and evaluation of treatment strategies
relevant to human. Investigation within canine populations has
identified a number of disease models, and the present studies
aimed to document and investigate a retinal phenotype ob-
served within a population of pit bull terrier derived animals.
The disease in adult dogs is broadly similar to other early on-
set hereditary retinal degenerations in the dog, but the differ-
ences seen in younger dogs are likely to be more significant.
In particular, compared to rod-cone dysplasia type 1 (rcd1),
for example, the early severe loss of cone function as assessed
both by ERG and clinical assessment of visual function is strik-
ing. In rcd1 the primary cell biologic defect affects rods, and
cones only seem to die as a consequence of the loss of rods.
This is also generally held to be true for other forms of PRA
and for RP. In the present disease, however, cone dysfunction
is at least synchronous with the rod dysfunction, and is the
main cause of the early clinical manifestations. No other form
of PRA exhibits dayblindness as early as do these affected
dogs, and no other form of PRA exhibits such early, rapid, and
severe loss of cone ERG function both in absolute terms and
relative to the loss of rod function. We therefore classify their
disease as an early onset cone rod dystrophy.
Because morphologic examination of affected eyes has
so far been from dogs over 6 months of age, we have only
limited insight into the natural history of either disease or the
differences between crd1 and crd2, except that both are ex-
tremely fast and severe. Further studies of much younger af-
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Figure 6. Association data for CFA6 polymorphisms in a pedigree
segregating a canine cone-rod dystrophy.  Association data for CFA6
polymorphisms within a subset of pedigrees segregating canine cone-
rod dystrophy. Haplotypes derived from two CFA6 microsatellites
(2A11 and C06.636) and two exonic ABCA4 point substitutions are
shown below each animal. The horizontal line indicates a recombi-
nation event observed in animal 25.
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fected tissues will be necessary to better understand these dis-
eases.
Breedings designed to test allelism of the disease(s) af-
fecting the two founders produced ten offspring all of which
proved non-affected, by criteria that reliably demonstrate dis-
ease in inbred affected descendants of either founder. This un-
expectedly established that the phenotype in these dogs repre-
sents not one new disease but two different, non-allelic dis-
eases. That is, the diseases in the two founders derive from
non-allelic mutations. For mapping the disease locus in these
pedigrees, and evaluation of candidate genes, it is thus critical
to evaluate each arm of the pedigree independently. For these
reasons we refer to the locus and disease derived from Animal
3 as crd1, and from Animal 1 as crd2, for cone rod dystrophy
type 1 and 2, respectively. In young animals, it is possible to
distinguish crd1 from crd2, as cone ERG function in the former
is apparently absent at the earliest age tested, but in the latter,
although severely reduced, it is recordable. In retrospect this
difference was present between the ERGs recorded from ani-
mals 73 and 78 used in the complementation test (data not
shown), but at the time was thought to be within the range of
variation of what was expected to be a single disease. This
difference disappears in older dogs as the diseases progress.
The number of genes or loci currently identified with CRD
in humans is relatively few, compared to those for RP. Only
four, ABCA4 (HSA) [10,11,23-25], CORD8 (HSA1q12-q24)
[26], CORD9 (HSA8p11) [27], and RPGRIP1 (14q11) [28],
have so far been incriminated in nonsyndromic autosomal re-
cessive CRD. Of these 4 loci, ABCA4 appears to account for a
plurality of known autosomal recessive CRD patients
[11,23,24]. As a first step towards identifying the genes in-
volved in crd1 and crd2, ABCA4 was therefore selected to be
tested as a candidate gene.
Retinal mRNA was used as the template to sequence all
50 exons of the wildtype canine ABCA4 homolog. This al-
lowed pairwise comparison of the nucleotide diversity with
both human and mouse ABCA4 and revealed a gene with higher
than average synonymous but lower than average non-syn-
onymous divergence. This likely reflects a gene which holds
a non-redundant metabolic function as amino acid level sub-
stitutions are heavily selected against. This is consistent with
the large number of identified pathogenic substitutions identi-
fied within human populations. Translation of the obtained
sequence and alignment with human ABCA4 revealed a ca-
nine protein with four less residues. Each of the four missing
amino acids are clustered in a region which has accumulated
many more interspecies substitutions than the average for the
entire protein, suggesting an ABCA4 region of lowered func-
tional significance. By contrast, those regions identified as
critical for function including the two ATP nucleotide binding
sites and transporter signature motifs [29] were almost com-
pletely conserved.
To evaluate the role of ABCA4 in the cone-rod dystrophy
disease described herein, comparative sequence analysis was
conducted for all 50 exons expressed in an affected (animal
22), a non-affected littermate (animal 23) and a homozygous
wildtype colony animal (P1117). Three non-synonymous sub-
stitutions were identified however none appear to contribute
to canine crd. A Glu627Ala substitution was observed in the
heterozygous state only within the normal animal P1117 and
is not among the growing list of 176 ABCA4 substitution
mutations associated with human retinal disease (Human Gene
Mutations Database). A Thr1322Ala substitution is homozy-
gous within the affected animal (22) and heterozygous in the
others, however Thr1322 is neither conserved within human
ABCA4 or its substitution implicated with human disease. In
addition, replacement of Thr1322 with a non-polar residue
(Ala) introduces an amino acid highly similar to Pro1322 found
in human ABCA4 indicating it is likely nonpathogenic in the
dog. The third non-synonymous substitution (Val1747 Ile) is
heterozygous in the affected animal and replacement of
Val1747 with Ile reconstitutes the amino acid present within
the human molecule.
The presence of heterozygous positions, when detected
within affected individuals, has been used as evidence to ex-
clude candidate genes from involvement in autosomal reces-
sive canine PRA [30,31]. Testing in this study revealed het-
erozygosity at ABCA4 exonic variants within a limited sample
of affected individuals from nine of the eleven breeds exam-
ined. While this argues against the involvement of ABCA4
with PRA in these breeds, it does not by itself constitute ex-
clusion. Pairwise LD between the two ABCA4 exonic SNPs
showed they are tightly linked but not in complete disequilib-
rium (the genotype at one does not perfectly predict the geno-
type at the other). Exons 13 and 27 are separated by only 25
kB in the human homolog which indicates a neutral polymor-
phism, even when located within the same gene and closely
linked to the mutation, may not be theoretically sufficient for
exclusion. A second impediment is that disease heterogeneity
may be more common in dog breeds than is widely recog-
nized. Thus, a causal gene might be falsely excluded if a dis-
ease resulted from compound heteroallelism and exclusion was
based solely on the presence of heterozygosity. Nonetheless,
it is considered unlikely that ABCA4 is a valid candidate gene
for the forms of PRA in the breeds examined.
Analysis of polymorphism within even a small pedigree,
as undertaken here for crd1 and crd2, however, ensures exclu-
sion of causal sequence variants in promoter or other regula-
tory elements physically located with the gene under investi-
gation. We therefore confidently conclude that ABCA4 can be
excluded as the gene causing either crd1 or crd2. This leaves
open the question of which genes do cause these diseases.
Because the canine retina developes postnatally, rather than
prenatally as in humans, it can be argued that one or both of
these 2 diseases might correspond to one of the apparently
earlier onset human diseases classified as Leber Congenital
Amaurosis. This would expand the list of candidate genes that
might be worth evaluating individually before undertaking a
genome wide screen. Such studies are currently underway.
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